Terms: = Pancreatic cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
154 results:
1. ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and pancreatic cancer Cells.
Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
[TBL] [Abstract] [Full Text] [Related]
2. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/nrf2 axis in pancreatic cancer.
Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
[TBL] [Abstract] [Full Text] [Related]
3. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
[TBL] [Abstract] [Full Text] [Related]
4. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
5. nrf2 interacts with distal enhancer and inhibits nitric oxide synthase 2 expression in KRAS-driven pancreatic cancer cells.
Di Giorgio E; Cortolezzis Y; Gualandi N; Agostini F; Rapozzi V; Xodo LE
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119606. PubMed ID: 37852325
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract] [Full Text] [Related]
7. Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy.
Zhang Y; Zhang Y; Tao H; Zhu J; Lu Y; Cheng F; Xiong Y; Liu J; Cai G; Zhang Z; Liang H; Chen Y; Zhang W
Cancer Lett; 2023 Nov; 576():216405. PubMed ID: 37783391
[TBL] [Abstract] [Full Text] [Related]
8. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
Wang X; Su S; Zhu Y; Cheng X; Cheng C; Chen L; Lei A; Zhang L; Xu Y; Ye D; Zhang Y; Li W; Zhang J
Nat Commun; 2023 Sep; 14(1):5778. PubMed ID: 37723178
[TBL] [Abstract] [Full Text] [Related]
9. [Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].
Huang XM; Zhang K; Yin J; Wu PF; Cai BB; Lu ZP; Tu M; Chen JM; Guo F; Xi CH; Wei JS; Wu JL; Gao WT; Dai CC; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):894-900. PubMed ID: 37653992
[No Abstract] [Full Text] [Related]
10. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing nrf2.
Cui J; Guo Y; Yin T; Gou S; Xiong J; Liang X; Lu C; Peng T
Biomed Pharmacother; 2023 Oct; 166():115359. PubMed ID: 37639742
[TBL] [Abstract] [Full Text] [Related]
11. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
12. Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing nrf2 activity.
Ruan Q; Wen C; Jin G; Yuan Z; Yang X; Wen Z; Huang G; Li G; Deng J; Bai Y
Phytomedicine; 2023 Sep; 118():154990. PubMed ID: 37494874
[TBL] [Abstract] [Full Text] [Related]
13. Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.
Wang Z; Li W; Wang X; Zhu Q; Liu L; Qiu S; Zou L; Liu K; Li G; Miao H; Yang Y; Jiang C; Liu Y; Shao R; Wang X; Liu Y
Chin Med J (Engl); 2023 Sep; 136(18):2210-2220. PubMed ID: 37488674
[TBL] [Abstract] [Full Text] [Related]
14. Ferroptosis model system by the re-expression of BACH1.
Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
[TBL] [Abstract] [Full Text] [Related]
15. Immunotoxicity induced by triclocarban exposure in zebrafish triggering the risk of pancreatic cancer.
Wang H; Li X; Wang W; Xu J; Ai W; Huang H; Wang X
Environ Pollut; 2023 May; 325():121458. PubMed ID: 36934961
[TBL] [Abstract] [Full Text] [Related]
16. Mechanical Regulation of Redox Balance via the Induction of the PIN1/nrf2/ARE Axis in pancreatic cancer.
Liang C; Rong Z; Tuerhong A; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Shi S; Xu J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834887
[TBL] [Abstract] [Full Text] [Related]
17. Cinchonine-induced cell death in pancreatic cancer cells by downregulating RRP15.
Liang F; Lv Y; Qiao X; Zhang S; Shen S; Wang C; Xu G; Zou X; Wang L; Zhang B
Cell Biol Int; 2023 May; 47(5):907-919. PubMed ID: 36682038
[TBL] [Abstract] [Full Text] [Related]
18. KRAS G12D mutation eliminates reactive oxygen species through the nrf2/CSE/H
Fan K; Zhang S; Ni X; Shen S; Wang J; Sun W; Suo T; Liu H; Ni X; Liu H
Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 54(11):1731-1739. PubMed ID: 36514219
[TBL] [Abstract] [Full Text] [Related]
19. Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate pancreatic cancer Progression by Activating nrf2/HO-1 Axis via Upregulating CCR2 Expression.
Guo Y; Chen T; Liang X; Gou S; Xiong J; Cui J; Peng T
Cells; 2022 Dec; 11(23):. PubMed ID: 36497150
[TBL] [Abstract] [Full Text] [Related]
20. Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis.
Chen T; Zhang X; Ding X; Feng J; Zhang X; Xie D; Wang X
Mol Oncol; 2023 Apr; 17(4):695-709. PubMed ID: 36453019
[TBL] [Abstract] [Full Text] [Related]
[Next]
